Sacheerome Earnings Call Transcript: Key Takeaways
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
H1 FY27 steady: income +9.84% to ₹85.92 Cr, PAT +12.38% to ₹16.79 Cr, EBITDA margin 27.57%. YEIDA plant in trial, commercial output awaits certificates. Capex and utilisation answers evasive.
H1 FY27: total income ₹8,592L (+9.84% YoY), EBITDA ₹2,369L (+12.27%), PAT ₹1,679L (+12.38%), EBITDA margin 27.57%. YEIDA trial production began Sep 2026.
Sacheerome reported H1 FY27 total income of Rs 8,592 Lakh, up 9.84%, and PAT up 12.38%. Its YEIDA facility began trial production in September 2026.
Sacheerome reported no deviation in IPO fund utilisation for the half year ended 30 September 2026. The filing is a routine Reg 32 proceeds statement.
Sacheerome Ltd reported revenue from operations of ₹84.5 Cr (+10.3% YoY) and net profit of ₹16.8 Cr (+12.8% YoY) for H1 FY27.
Sacheerome Limited intimated a board meeting scheduled for 31-Oct-2026 to consider unaudited half-yearly financial results for September 2026. The meeting has not yet been held; agenda items are proposed only.
Sacheerome Limited reported H1 FY27 revenue of ₹84.48 Cr. The company completed its new YEIDA facility, which commenced trial production in September 2026.
Sacheerome Limited has filed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Sacheerome Limited has commenced trial production at its new manufacturing facility located at Sector-32, YEIDA, U.P. Installation and commissioning of the plant are complete.
Sacheerome Limited held its 34th Annual General Meeting on September 24, 2026, via video conferencing to transact the planned agenda items.
Sacheerome Limited has issued the notice for its 34th Annual General Meeting, scheduled to be held on September 24, 2026, via video conferencing.
Sacheerome Limited has delayed the commissioning of its new manufacturing unit from August 2026 to September 2026 due to vendor issues. Commercial operations are expected to commence shortly.